Held, S.* ; Erck, C.* ; Kemppainen, S.* ; Bleibaum, F.* ; Giridhar, N.J.* ; Feederle, R. ; Krenner, C.* ; Juopperi, S.P.* ; Calliari, A.* ; Mentrup, T.* ; Schröder, B.* ; Dickson, D.W.* ; Rauramaa, T.* ; Petrucelli, L.* ; Prudêncio, M.I.* ; Hiltunen, M.* ; Lüningschrör, P.* ; Capell, A.* ; Damme, M.*
Physiological shedding and C-terminal proteolytic processing of TMEM106B.
Cell Rep. 44:115107 (2025)
Genetic variants in TMEM106B, coding for a transmembrane protein of unknown function, have been identified as critical genetic modulators in various neurodegenerative diseases with a strong effect in patients with frontotemporal degeneration. The luminal domain of TMEM106B can form amyloid-like fibrils upon proteolysis. Whether this luminal domain is generated under physiological conditions and which protease(s) are involved in shedding remain unclear. We developed a commercially available antibody against the luminal domain of TMEM106B, allowing a detailed survey of the proteolytic processing under physiological conditions in cellular models and TMEM106B-related mouse models. Moreover, fibrillary TMEM106B was detected in human autopsy material. We find that the luminal domain is generated by multiple lysosomal cysteine-type proteases. Cysteine-type proteases perform additional C-terminal trimming, for which experimental evidence has been lacking. The presented results allow an in-depth perception of the processing of TMEM106B, a prerequisite to understanding factors leading to fibril formation.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Cp: Cell Biology ; Cp: Neuroscience ; Ftld ; Sppl2a ; Tmem106b ; Cathepsins ; Fibrils ; Luminal Domain ; Lysosomes ; Proteolytic Processing ; Shedding; Frontotemporal Lobar Degeneration; Peptidase-like 2a; Risk-factor; Intramembrane Proteolysis; Sppl2a; Sars-cov-2; Variants; Mutation
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2025
Prepublished im Jahr
2024
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
2211-1247
e-ISSN
2211-1247
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 44,
Heft: 1,
Seiten: ,
Artikelnummer: 115107
Supplement: ,
Reihe
Verlag
Cell Press
Verlagsort
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
Institut(e)
CF Monoclonal Antibodies (CF-MAB)
POF Topic(s)
30201 - Metabolic Health
Forschungsfeld(er)
PSP-Element(e)
A-631900-001
Förderungen
MRC
DFG
Strategic Neuroscience Funding of the University of Eastern Finland
Sigrid Juselius Foundation
Research Council of Finland
ELA International
Alzheimer's Association through the AD Strategic Fund
BDR
Copyright
Erfassungsdatum
2025-01-09